Loading...

Becton, Dickinson and Company

BDX•NYSE
Healthcare
Medical - Instruments & Supplies
$146.95
$4.60(3.23%)
U.S. Market opens in 13h 47m

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap53.2B
P/E Ratio36.28
EPS (TTM)$5.72
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$156.25
3 Months$137.73
1 Year Target$157.39

BDX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $157.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.28 and a market capitalization of 53.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.24%
5-Day Change
1.22%
1-Month Change
-7.30%
3-Month Change
-19.46%
6-Month Change
-2.24%
Year-to-Date (YTD) Change
-3.68%
1-Year Change
5.58%
3-Year Change
-25.79%
5-Year Change
-21.03%
All-Time (Max) Change
535.64%

Contact Information

https://www.bd.com
201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

70,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions